Thursday
Mar262009
New policy for old drugs
Coffee Brown, University of New Mexico, Talk Radio News
Sens. Chuck Schumer (D-N.Y.), Susan Collins (R-Maine), Sherrod Brown (D-Ohio), and Mel Martinez (R-Fla.) announced the Promoting Innovation and Access to Life-Saving Medicine Act, to make generic alternatives available as “biologics” go out of parent.
Schumer joked that he couldn't make an acronym out of the initials, then explained biologics are drugs produced from living cells, (such as Premarin from horses, vaccines from killed or weakened microbes, Insulin from bacteria, or the anticipated results of stem cell research).
Collins said the act is needed because currently the FDA has no pathway to evaluate and approve this class of drugs. Many lifesaving biologics are long out of patent, but are still expensive because generics can’t get approved. “The price tag (for insulin) might well drop by as much as 25 percent,” she said.
Brown and Martinez agreed that there was strong bipartisan support for the act.
“We probably have four different opinions here about here on the best way to proceed on healthcare reform, but everyone agrees a prerequisite is to bring costs down," Schumer said.
The summary of the bill contained a clause limiting “exclusivity” (like a patent) to five years for the original molecule and three years for some modifications.
Low-hanging fruit.
Coffee Brown, University of New Mexico, Talk Radio News
The Alliance for Health Reform presented findings of recent pilot studies showing that major improvements in healthcare are possible now, even in advance of new technologies and structures.
Ed Howard, Alliance for Health Reform, said that less than two percent of hospitals have “fully integrated” Health Information Technology (HIT). Even as hospitals invest in hardware, software, and training, the systems won’t work unless everyone uses them, he said. Where HIT is used effectively, he finished, quality and cost control are measurably improved. In other words, HIT does deliver better, faster, less expensive care.
But only when its use is coordinated among providers (often called “Care Teams”), according to Carolyn M. Clancy, MD, Director of the Agency for Healthcare Research and Quality (AHRQ). When the Electronic Medical Record (EMR) merely recreates the chart as an electronic document, “it can actually allow us to make the same mistakes faster.”
She cited the Provnost Study showing that when computers helped to coordinate care among all of the caregivers, using checklists, prompts, and feedback, infected lines in the ICU were reduced nearly to zero.
Jon Rasmussen, Pharm. D., Chief of Clinical Pharmacy Cardiovascular Services, and Susan Kuca, RN, Cardiac Care Coordinator, described Kaiser Permanente’s intricately coordinated care. They said the program had reduced the risk of subsequent fatal heart attack by 88 percent if begun immediately after hospitalization, and by 73 percent even if started much later, such as when a patient with existing heart disease came into the system from elsewhere.
Greg Halvorson, Chairman and CEO of Kaiser Permanente Health Plan, said we are the only industrialized country without universal health care. He said healthcare can and should be both better and more affordable. Halvorson described a RAND study covering 5 million patients over 2 years that found 25 percent of care was wrong or harmful, implying that U.S. savings in healthcare from efficiency alone could be one-half to one trillion dollars.
Diabetics account for 30 percent of Medicaid dollars, yet their carewas rated as “right only eight percent of the time.”
Big deductibles had the opposite of their intended effect by causing beneficiaries to delay care too long, he said.
In the case of chronic care, one percent of patients use 35 percent ofthe dollars, and ten percent use 80 percent of total dollars. “Chronic
care is a team sport,” Halvorson said.
The consensus of the panel was that, even without a single new treatment or device, coordination of ongoing care could save billions
or trillions of dollars, while improving outcomes.